Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6319760 | 0.92 | — | — | |
| SCHEMBL6272311 | 0.87 | CYP1A2 (0.32) | CYP1A2CYP3A4GAACYP2C9CYP2C19 | |
| SCHEMBL6317163 | 0.86 | CYP1A2 (0.31) | CYP1A2CYP3A4GAACYP2C9CYP2C19 | |
| SCHEMBL6317892 | 0.85 | — | — | |
| SCHEMBL6324620 | 0.85 | CYP1A2 (0.32) | CYP1A2CYP3A4GAACYP2C9CYP2C19 | |
| SCHEMBL6270667 | 0.82 | CYP1A2 (0.31) | CYP1A2CYP3A4GAACYP2C9CYP2C19 | |
| SCHEMBL6319409 | 0.82 | GAA (0.33) | CYP1A2CYP3A4GAACYP2C9CYP2C19 | |
| SCHEMBL6318094 | 0.81 | — | — | |
| SCHEMBL6319223 | 0.79 | — | — | |
| SCHEMBL6268716 | 0.78 | MAPT (0.31) | GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050143349-A1 | Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels | QUATRX PHARMACEUTICALS CO. | 2005-06-30 | — | — | US | claimed |
| US-20050143349-A1 | Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels | QUATRX PHARMACEUTICALS CO. | 2005-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050143349-A1 | Phosphorus containing compounds useful for the regulation of LDL and Lp(a) levels | APOB, LDLR, LPL | CYP1A2 2243/4885CYP3A4 2216/4885GAA 1102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.